Global Contract Research Organization Market Deals and Operational Strategies - The US is at The Center of Deal Activity in The CRO Market

DUBLIN, Oct. 8, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/jsrrgj/contract_research) has announced the addition of the "Contract Research Organization Market - Global Deals and Operational Strategies" report to their offering.

This report discusses the deals that took place in the CRO space between 2010 and April 2015, giving a thorough analysis of the major deals, operational and service strategies, and financials of key players.

This report discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management. SWOT analysis and profiles are given for the key companies in the market.

Recent years have seen pharmaceutical companies struggling to balance R&D expenditure and profitability due to the rising costs of drug development and clinical trials, along with rigorous regulatory and quality assurance requirements. In a bid to boost profit margins, companies are outsourcing R&D and clinical trial activities to Contract Research Organizations (CRO) to achieve far more at a far lower cost.

Scope

- Overview of key reasons behind outsourcing, outsourcing service models - Examples of operational strategies - Global deals analysis by type and value - Major acquisitions and partnerships - Regional analysis of North America, Europe, Asia-Pacific and Emerging markets - Company benchmarking based on heatmap analysis - Vendor positioning - SWOT analysis and profiles of key players

Key Reasons to Purchase

- Identify the top players in the CRO market, financial revenues and key services offered - Analyze the key geographies that are lucrative markets for deal making, market-entry and market expansion strategies - Analyze the trends in acquisitions, licensing and other type of deals and explore potential investment opportunities - Understand the operational strategies of key players

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Market Dynamics

2.2 Operating Models

2.3 Examples of Operational Strategies

3. Global Deal Analysis 3.1 Collaborations and Acquisitions 3.2 Major Acquisitions 3.3 Major Partnerships

4. Regional Analysis

4.1 North America

4.2 Europe

4.3 Asia-Pacific

5. Emerging Markets 5.1 Market Assessment 5.2 Acquisitions 5.3 Firm Utilization 5.4 Firm Utilization and Capital Management 5.5 Company Benchmarking 5.6 Vendor Positioning

6. Profiles and SWOT Analysis

7. Appendix

Companies Mentioned

- Almac Group

- Assign

- Aurigon

- Avillion

- BioPharma

- CMIC Holdings

- Carlina

- Catalent

- Celonic and PharmaLex

- Charles River

- Chiltern International

- Consort Medical

- Covance

- Cromos Pharma

- EPS Corporation

- Euprotech

- Eurofins Scientific

- Hangzhou Tigermed

- Harlan Labs

- ICON

- Laboratory Corporation of America Holdings

- MPI Research

- Meiji Seika

- Noble Life Sciences

- Novotech

- PRA Health

- Parexel

- Pfizer

- Protagen

- Quintiles

- Recipharm

- Sanofi

- Simbec Research

- Sun Pharma

- WuXi PharmaTech

For more information visit http://www.researchandmarkets.com/research/jsrrgj/contract_research

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com